Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1381 studies found for:    Open Studies | "Virus Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Virus Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults
Conditions: Virus Diseases;   RNA Virus Infections;   Respiratory Tract Diseases;   Respiratory Tract Infections
Interventions: Biological: Low dose of quadrivalent VLP vaccine;   Biological: Medium dose of quadrivalent VLP vaccine;   Biological: High dose of quadrivalent VLP vaccine;   Biological: Placebo
2 Unknown  The Development of a Human Model of Respiratory Syncytial Virus Infection
Conditions: Respiratory Syncytial Virus Infections;   Respiratory Viral Infections
Intervention: Biological: RSV A Memphis 37
3 Recruiting Respiratory Syncytial Virus - RSV Protocol
Conditions: Bone Marrow Transplant Infection;   Infection in Marrow Transplant Recipients;   Respiratory Syncytial Virus Infections;   Respiratory Syncytial Virus Pneumonia;   Cancer;   Acute Leukemia
Intervention: Drug: Ribavirin
4 Recruiting Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal VLP Quadrivalent Influenza Vaccine in the Elderly Population
Conditions: Virus Diseases;   RNA Virus Infections;   Respiratory Tract Diseases;   Respiratory Tract Infections
Interventions: Biological: Non-adjuvanted low dose of quadrivalent VLP vaccine;   Biological: Non-adjuvanted medium dose of quadrivalent VLP vaccine;   Biological: Non-adjuvanted high dose of quadrivalent VLP vaccine;   Biological: Adjuvanted low dose of quadrivalent VLP vaccine;   Biological: Adjuvanted high dose of quadrivalent VLP vaccine;   Biological: Placebo
5 Recruiting A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 (HIV-1) Coinfection
Conditions: Hepatitis C Virus Infection;   Human Immunodeficiency Virus Infection;   Chronic Hepatitis C;   Compensated Cirrhosis and Non-cirrhotics
Interventions: Drug: ABT-450/r/ABT-267;   Drug: ABT-333;   Drug: Ribavirin (RBV)
6 Recruiting Efficacy of Favipiravir Against Ebola (JIKI)
Condition: Ebola Virus Disease
Intervention: Drug: Favipiravir
7 Recruiting Phase II of Chemotherapy for Relapsed Epstein Barr Virus Associated Lymphoma
Conditions: Epstein Barr Virus Associated Non Hodgkin's Lymphoma;   Epstein Barr Virus Associated Hodgkin's Lymphoma;   Post-Transplant Lymphoproliferative Disease
Interventions: Drug: Doxorubicin;   Drug: Methotrexate;   Drug: Leucovorin;   Biological: Hydroxyurea;   Drug: Zidovudine;   Procedure: Urine Alkalization
8 Recruiting Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Condition: Hepatitis C Virus Infection
Interventions: Drug: GS-9857;   Drug: Placebo to match GS-9857
9 Recruiting Respiratory Virus Hospitalization Study (FLU 003 Plus)
Conditions: Influenza;   Novel Respiratory Virus-1 MERS-CoV;   Novel Respiratory Virus-2 SARS-CoV
Intervention:
10 Recruiting Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody Therapy
Conditions: Lower Respiratory Tract Infection;   Respiratory Syncytial Virus Infections
Intervention:
11 Recruiting Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against Epstein Barr Virus, Adenovirus, And Cytomegalovirus
Conditions: Epstein-Barr Virus Infections;   Adenovirus;   Cytomegalovirus Infections
Intervention: Biological: Cytotoxic T Lymphocytes
12 Not yet recruiting Chronic Fatigue Following Acute Epstein-Barr Virus Infection in Adolescents
Conditions: Fatigue Syndrome, Chronic;   Epstein-Barr Virus Infections
Intervention:
13 Recruiting A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With and Without Ribavirin in Adults With Chronic Hepatitis C Virus Infection
Condition: Chronic Hepatitis C Virus Infection
Interventions: Drug: Ombitasvir/ABT-450/r;   Drug: Sofosbuvir;   Drug: Ribavirin (RBV)
14 Recruiting Viral Infections in Healthy and Immunocompromised Hosts
Condition: Herpes Viruses
Intervention:
15 Recruiting GS-5806 in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract
Condition: Respiratory Syncytial Virus
Interventions: Drug: GS-5806;   Drug: Placebo
16 Recruiting Clinical Trial to Evaluate the Efficacy and Safety of Convalescent Plasma for Ebola Treatment
Condition: Ebola Virus Disease
Intervention: Procedure: Convalescent Plasma Treatment
17 Not yet recruiting Most Closely Human Leukocyte Antigen (HLA)-Matched BK Virus-specific T Lymphocytes (Viralym-B)
Condition: BK Virus Infection
Intervention: Biological: Viralym-B
18 Recruiting Genetic Studies of Chronic Active Epstein-Barr Disease
Condition: Epstein-Barr Virus Infections
Intervention:
19 Unknown  Biliverdin Reductase A in Chronic Hepatitis C Virus Infection
Condition: Hepatitis C Virus Infection
Intervention:
20 Recruiting A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma
Conditions: Nasopharyngeal Cancer;   Epstein Barr Virus Infections
Intervention: Drug: MVA-EBNA1/LMP2 vaccine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years